Psoriasis vulgaris (PV) is a common inflammatory skin disorder with a complex genetic architecture. While large genome-wide association studies have identified many susceptibility loci, family-based approaches can be more powerful for detecting segregating, potentially high-impact variants in pedigrees. The authors applied an integrative family-centered strategy to identify candidate genetic contributors to PV and to explore links between genetic variation, inflammation, and metabolic comorbidities.
The study performed whole exome sequencing (WES) on members of a PV-affected nuclear family. Identified variants were analyzed with integrative computational methods. Structural modeling and molecular dynamics simulations were used to assess the potential effects of prioritized variants on protein structure, stability, and function. Literature-based interpretation was applied to explore biological plausibility and connections to inflammation and metabolic dysfunction.
Analysis of the WES data revealed a heterozygous splice site variant, c.905+1 G>T, in the SERPINA12 gene that segregated with PV in the studied family. The variant is reported as a splice donor site change. The authors present segregation as the basis for implicating this variant in familial PV within the pedigree they studied. The source does not provide additional independent cohort replication or population frequency details in this report.
To evaluate the likely molecular consequences of the splice site variant, the investigators used structural modeling and molecular dynamics simulations. These computational analyses indicated destabilization of the protein’s C-terminal region. Based on the modeling, the predicted effect is impairment of the protein’s serine protease inhibitor activity. The source reports that these in silico results suggest altered stability and functional disruption, but no in vitro or in vivo functional assays were reported in the preprint.
SERPINA12 encodes the adipokine vaspin, which has been described in the literature as possessing anti-inflammatory properties, in part via inhibition of serine proteases. The authors propose that the identified splice site change reduces vaspin’s ability to inhibit kallikrein 7 (KLK7), diminishing vaspin’s anti-inflammatory activity. This mechanistic hypothesis is based on the structural predictions and prior literature linking vaspin, KLK7, and inflammatory pathways. The report frames this vaspin–KLK7 axis as a potential contributory mechanism in PV pathogenesis for the family studied.
The authors discuss a potential connection between the SERPINA12 variant, inflammation in PV, and metabolic disorders such as type 2 diabetes mellitus. Because vaspin is an adipokine with roles in metabolic regulation, the report interprets the predicted functional impairment as a possible link between cutaneous inflammation and metabolic comorbidities. These implications are presented as hypothesis-generating; the source does not report clinical metabolic data from the family or experimental metabolic assays to directly substantiate this link.
The authors state that WES data supporting the findings are available from the corresponding author upon reasonable request and subject to ethical approval and data protection regulations. Structural modeling and molecular dynamics data are likewise available. Ethical approval for the research was provided by the Regional Ethical Committee for the Protection of Persons, southern Tunisia, under the Ministry of Health, and participant consent procedures were followed. The authors declare no competing interests.
Limitations noted or inferable from the source material include the single-family design without reported external replication, reliance on computational prediction rather than functional laboratory confirmation, and absence of reported population allele frequency or broader case-control evidence within this preprint. The proposed vaspin–KLK7 mechanism is supported by structural simulation and literature interpretation but requires experimental validation and larger genetic studies to confirm causality and prevalence.
Conclusions
Using a family-based WES strategy, the study identifies a heterozygous SERPINA12 splice site variant (c.905+1 G>T) that segregates with psoriasis vulgaris in a Tunisian nuclear family. Computational structural analyses predict destabilization of the protein’s C-terminal region and impaired serine protease inhibitory function, leading the authors to propose reduced vaspin inhibition of KLK7 as a pathogenic axis connecting cutaneous inflammation and metabolic comorbidity risk. The findings are presented as preliminary and hypothesis-generating, with underlying sequence and simulation data available on request and further validation needed.